On December 9, 2025, our CEO/CSO, Dr. Tamaki, will speak at the 469th CBI Society Seminar titled “Latest Trends in AI Agents: Learning from History, Case Studies, and Future Perspectives”, organized by the Chem-Bio Informatics Society (CBI Society). The seminar will be held online and will be conducted in Japanese.

From 16:35 JST, Dr. Tamaki will give a talk entitled “AI-Driven Antibody Design Utilizing Language Models and AI Agents”. In this session, he will present the development of AI agents built around our proprietary large language model specialized for antibodies, which autonomously execute tasks in drug discovery workflows. He will also share practical implementation examples of these AI agents in antibody design.
For more information, please visit the official event website (link). We look forward to meeting you online.